ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

Funding Opportunities.

July 19, 2002

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

In Brief: Resolution Seeks Two-Fold Increase For NIH; Hartwell Named President At Fred Hutchinson

January 31, 1997

Guest Editorial: The Supreme Court Decision on the ACA and What It Can Mean to Oncology

June 29, 2012